223 related articles for article (PubMed ID: 34061962)
21. Synthesis and glycosylation of proopiomelanocortin by a Cushing tumor.
Miller WL; Johnson LK
J Clin Endocrinol Metab; 1982 Sep; 55(3):441-6. PubMed ID: 6284780
[TBL] [Abstract][Full Text] [Related]
22. Proopiomelanocortin, glucocorticoid, and CRH receptor expression in human ACTH-secreting pituitary adenomas.
Cassarino MF; Sesta A; Pagliardini L; Losa M; Lasio G; Cavagnini F; Pecori Giraldi F
Endocrine; 2017 Mar; 55(3):853-860. PubMed ID: 27220856
[TBL] [Abstract][Full Text] [Related]
23. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
Auernhammer CJ; Melmed S
Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
[TBL] [Abstract][Full Text] [Related]
25. Proopiomelanocortin gene expression and DNA methylation: implications for Cushing's syndrome and beyond.
Newell-Price J
J Endocrinol; 2003 Jun; 177(3):365-72. PubMed ID: 12773116
[TBL] [Abstract][Full Text] [Related]
26. Identification of recurrent USP48 and BRAF mutations in Cushing's disease.
Chen J; Jian X; Deng S; Ma Z; Shou X; Shen Y; Zhang Q; Song Z; Li Z; Peng H; Peng C; Chen M; Luo C; Zhao D; Ye Z; Shen M; Zhang Y; Zhou J; Fahira A; Wang Y; Li S; Zhang Z; Ye H; Li Y; Shen J; Chen H; Tang F; Yao Z; Shi Z; Chen C; Xie L; Wang Y; Fu C; Mao Y; Zhou L; Gao D; Yan H; Zhao Y; Huang C; Shi Y
Nat Commun; 2018 Aug; 9(1):3171. PubMed ID: 30093687
[TBL] [Abstract][Full Text] [Related]
27. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
Bertagna X
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
29. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.
Stefaneanu L; Kovacs K; Horvath E; Lloyd RV
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):107-13. PubMed ID: 1651583
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel
Uzilov AV; Cheesman KC; Fink MY; Newman LC; Pandya C; Lalazar Y; Hefti M; Fowkes M; Deikus G; Lau CY; Moe AS; Kinoshita Y; Kasai Y; Zweig M; Gupta A; Starcevic D; Mahajan M; Schadt EE; Post KD; Donovan MJ; Sebra R; Chen R; Geer EB
Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001602. PubMed ID: 28487882
[TBL] [Abstract][Full Text] [Related]
31. Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease.
Lu J; Chatain GP; Bugarini A; Wang X; Maric D; Walbridge S; Zhuang Z; Chittiboina P
J Clin Endocrinol Metab; 2017 Aug; 102(8):2825-2835. PubMed ID: 28505327
[TBL] [Abstract][Full Text] [Related]
32. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease.
Hayashi K; Inoshita N; Kawaguchi K; Ibrahim Ardisasmita A; Suzuki H; Fukuhara N; Okada M; Nishioka H; Takeuchi Y; Komada M; Takeshita A; Yamada S
Eur J Endocrinol; 2016 Feb; 174(2):213-26. PubMed ID: 26578638
[TBL] [Abstract][Full Text] [Related]
33. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.
Perez-Rivas LG; Theodoropoulou M; Ferraù F; Nusser C; Kawaguchi K; Stratakis CA; Faucz FR; Wildemberg LE; Assié G; Beschorner R; Dimopoulou C; Buchfelder M; Popovic V; Berr CM; Tóth M; Ardisasmita AI; Honegger J; Bertherat J; Gadelha MR; Beuschlein F; Stalla G; Komada M; Korbonits M; Reincke M
J Clin Endocrinol Metab; 2015 Jul; 100(7):E997-1004. PubMed ID: 25942478
[TBL] [Abstract][Full Text] [Related]
34. High expression of the POU factor Brn3a in aggressive neuroendocrine tumors.
Leblond-Francillard M; Picon A; Bertagna X; de Keyzer Y
J Clin Endocrinol Metab; 1997 Jan; 82(1):89-94. PubMed ID: 8989239
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
Farrell WE; Stewart MF; Clark AJ; Crosby SR; Davis JR; White A
J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas.
Pereda MP; Lohrer P; Kovalovsky D; Perez Castro C; Goldberg V; Losa M; Chervín A; Berner S; Molina H; Stalla GK; Renner U; Arzt E
Exp Clin Endocrinol Diabetes; 2000; 108(3):202-7. PubMed ID: 10926317
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
[TBL] [Abstract][Full Text] [Related]
38. Liver X receptor-α/β expression ratio is increased in ACTH-secreting pituitary adenomas.
Hashimoto K; Matsumoto S; Ishida E; Miura A; Horiguchi K; Ozawa A; Shibusawa N; Satoh T; Yamada M; Yamada S; Mori M
Neurosci Lett; 2011 Apr; 494(1):34-7. PubMed ID: 21356276
[TBL] [Abstract][Full Text] [Related]
39. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
[TBL] [Abstract][Full Text] [Related]
40. Structure of the POMC promoter region in pituitary and extrapituitary ACTH producing tumors.
Mönig H; Ali IU; Oldfield EH; Schulte HM
Exp Clin Endocrinol; 1993; 101(1):36-8. PubMed ID: 8386673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]